| 000 | 01685 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250514070422.0 | ||
| 264 | 0 | _c20031212 | |
| 008 | 200312s 0 0 eng d | ||
| 022 | _a0020-7292 | ||
| 024 | 7 |
_a10.1016/s0020-7292(03)00042-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMeydanli, M M | |
| 245 | 0 | 0 |
_aLabor induction post-term with 25 micrograms vs. 50 micrograms of intravaginal misoprostol. _h[electronic resource] |
| 260 |
_bInternational journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics _cJun 2003 |
||
| 300 |
_a249-55 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdministration, Intravaginal |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCervical Ripening _xdrug effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 | _aInfant, Postmature |
| 650 | 0 | 4 | _aLabor, Induced |
| 650 | 0 | 4 |
_aMisoprostol _xadministration & dosage |
| 650 | 0 | 4 |
_aOxytocics _xadministration & dosage |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 | _aPregnancy Outcome |
| 650 | 0 | 4 |
_aPregnancy Trimester, Third _xdrug effects |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aCalişkan, E | |
| 700 | 1 | _aBurak, F | |
| 700 | 1 | _aNarin, M A | |
| 700 | 1 | _aAtmaca, R | |
| 773 | 0 |
_tInternational journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics _gvol. 81 _gno. 3 _gp. 249-55 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0020-7292(03)00042-0 _zAvailable from publisher's website |
| 999 |
_c12553973 _d12553973 |
||